Loss of serum HBsAg after interferon‐A therapy in liver transplant patients with recurrent hepatitis‐B infection
Z Ben‐Ari, D Shmueli, Z Shapira, E Mor, R Tur‐Kaspa – 30 December 2003 – Reinfection with hepatitis B virus after orthotopic liver transplantation is nearly universal in patients who have not received posttransplant immunoprophylaxis. Recurrence almost invariably leads to chronic liver disease. Interferon has been used both prophylactically and therapeutically but has not been effective.